MRSH vs VBNK: fair value comparison
Marsh & McLennan Companies, Inc. and VersaBank · Updated 2026-10-19
MRSH has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. VBNK reports in CAD, so no same-currency fair-value verdict is published for it. Within Financial Services, VBNK currently ranks higher by quality score.
| MRSH | VBNK | |
|---|---|---|
| Verdict | No estimate yet | Awaiting full valuation |
| Last price | $188.35 | $22.09 |
| 12-month range | $157.32–$197.59 | $11.26–$23.72 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #141 of 207 Financial Services | #139 of 207 Financial Services |
| Quality grade | D | D |
| Leverage | High | Low |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Overbought | Neutral |
| 50/200-day trend | — | Uptrend |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: MRSH fair value analysis · VBNK fair value analysis